COMMUNIQUÉS West-GlobeNewswire

Grant of Restricted Stock Units and Warrants to Employees in Genmab

26/09/2024 - 21:17

Company Announcement COPENHAGEN, Denmark; September 26, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees of the Company and [...]

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

26/09/2024 - 20:00

REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent [...]

Corza Medical remporte le Prix d’excellence mondial 2024 du fabricant de solutions de suture de plaies le plus innovant

26/09/2024 - 19:12

WESTWOOD, Massachusetts, 26 sept. 2024 (GLOBE NEWSWIRE) -- Corza Medical (« Corza » ou la « Société »), une entreprise de technologie médicale de premier rang à l’échelle mondiale, proposant des services remarquables, [...]

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome

26/09/2024 - 18:34

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved engraftment and bone marrow [...]

Culture Biosciences Appoints Chris Williams as Chief Executive Officer

26/09/2024 - 18:05

Former COO of Cytek Biosciences brings extensive bioprocessing experience to drive next phase of growth at Culture Biosciences South San Francisco, CA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Culture Biosciences, a leader in [...]

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update

26/09/2024 - 18:00

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update Financial and business highlights Total H1 2024 incomes of €82.5 million thanks to Company’s new partnerships. New strategic [...]

OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le point sur ses avancées

26/09/2024 - 18:00

OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le point sur ses avancées Éléments financiers et business développement Revenus du premier semestre 2024 de 82,5 millions d’euros grâce [...]

Vistin Pharma ASA: Mandatory notification of trade

26/09/2024 - 17:27

Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure [...]

Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines

26/09/2024 - 16:30

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the [...]

Bavarian Nordic Upgrades its Financial Guidance for 2024

26/09/2024 - 16:30

COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024. Based on today’s announced mpox vaccine order and additional orders secured, combined with improved [...]

Urteste Expands Development of Innovative Diagnostic Projects

26/09/2024 - 16:29

Urteste Expands Development of Innovative Diagnostic Projects Gdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT), a biotechnology company specializing in the development of [...]

Acentra Health Earns Recertification to ISO 9001:2015 Standard for its Quality Management System

26/09/2024 - 16:23

Adherence to rigorous certification standards reinforces Acentra Health’s client-first commitment to delivering maximum value and impact with high quality solutions and services MCLEAN, Va., Sept. 26, 2024 (GLOBE [...]

BioNTX Announces 2024 Tech Transfer Showcase Finalists Pitch Competition at the 2024 iC³ Life Science & Healthcare Innovation Summit

26/09/2024 - 16:00

ARLINGTON, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- BioNTX is pleased to announce the finalists for the 3 rd Annual Tech Transfer Showcase, set for Friday, October 4th, at the 2024 iC³ Life Science & Healthcare [...]

CannaCon Midwest Convenes in Cleveland October 2024

26/09/2024 - 15:35

CLEVELAND, Sept. 26, 2024 (GLOBE NEWSWIRE) -- via CannabisNewsWire (“CNW”) — CannaCon , a first-class conference company producing state-of-the-art B2B events for cannabis businesses, marijuana entrepreneurs, investors [...]

New Research Findings Reveal Employers Who Contribute to HSAs See Double-Digit Growth in Employee Participation

26/09/2024 - 15:23

New HealthEquity research indicates employers who optimize HSA contribution strategies are more directly supporting their employees’ financial well-being DRAPER, Utah, Sept. 26, 2024 (GLOBE NEWSWIRE) -- HealthEquity, [...]

Kaida BioPharma to Present at BioSparkVA Pitch Event

26/09/2024 - 15:15

FORT LAUDERDALE, FL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), an early-stage pharma company dedicated to advancing ovarian cancer treatment through innovative drug development, [...]

GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

26/09/2024 - 15:15

SAN FRANCISCO, CALIFORNIA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the [...]

Safety Shot Spins Off Caring Brands Business with Plans to Issue a Dividend to Shareholders

26/09/2024 - 15:15

The Company is Divesting its Wellness Unit to Create Value for Shareholders and to Focus on Commercialization of its Safety Shot Dietary Supplement JUPITER, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Safety Shot , Inc. ( [...]

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX

26/09/2024 - 15:05

The intended selling valuation represents an increase of 47 % from the valuation at the time of SciSparc’s initial investment in MitoCareX Bio TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: [...]